I reported previously (see here) on the twisted spine treatment from Israel’s Apifix. The U.S. FDA has given Humanitarian Device Exemption (HDE) to Apifix to market its MID-C system. Apifix addresses the unmet clinical need for an alternative to spinal fusion.

https://www.businesswire.com/news/home/20190827005604/en/ApiFix-Receives-FDA-Approval-Commercialize-MID-C-System